No summary has been written for this.
GraniteShares YieldBOOST Biotech ETF is an actively managed exchange-traded fund that focuses on the biotechnology sector. Its current strategy is built around options-based income generation, primarily by selling put options on leveraged biotech-linked ETFs tied to the S&P Biotechnology Select Industry Index. The fund is designed to provide weekly distributions while maintaining exposure to the biotechnology theme through its derivatives framework. It is intended for investors seeking a biotech-focused fund with an income-oriented structure rather than direct stock selection. GraniteShares YieldBOOST Biotech ETF is part of GraniteShares’ YieldBOOST platform and operates as a U.S.-domiciled, non-diversified ETF within the derivative income category. Its role in the market is to offer a specialized biotechnology allocation combined with a systematic options strategy, making it distinct from traditional sector ETFs that primarily track equities outright.
No summary yet.
No summary yet.
No summary yet.
Investors talking about BIOY also mention these. Each card shows that asset’s own numbers for the past 24 hours.